Multiple site-specific in vitro labeling of single-chain antibody

Bioconjugate Chemistry

Volumn 20, Issue 7, 2009, Pages 1383-1389

  Ramakrishnan, Boopathy ^a   Boeggeman, Elizabeth ^a   Manzoni, Maria ^a   Zhu, Zhongyu ^a   Loomis, Kristin ^a   Puri, Anu ^a   Dimitrov, Dimiter S ^a   Qasba, Pradman K ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODIES; CELL CULTURE; CHAINS; ESCHERICHIA COLI; FLUORESCENCE; MOLECULES; POLYPEPTIDES; PROBES; RECOMBINANT PROTEINS;

BIOACTIVE MOLECULES; FUSION PROTEINS; GLYCOSYLATED; IN-VITRO; LABELINGS; SIDE-CHAINS; SINGLE-CHAIN ANTIBODIES; SITE-SPECIFIC; SPECIFIC CONJUGATIONS; THREONINE RESIDUES;

AMINO ACIDS;

2 KETO GALACTOSE; ALEXA 488; CARBOHYDRATE DERIVATIVE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FLUORESCENT DYE; GLYCOCONJUGATE; HYBRID PROTEIN; N ACETYLGALACTOSAMINE; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; THREONINE; UNCLASSIFIED DRUG;

ANTIBODY LABELING; ANTIGEN BINDING; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DRUG CONJUGATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PROTEIN FOLDING; PROTEIN GLYCOSYLATION;

EID: 67650676003     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc900149r     Document Type: Article

References (22)

1. Carter, P. J., and Senter, P. D. (2008) Antibody-drug conjugates for cancer therapy. Cancer J. 14, 154-69.
2. Deonarain, M. P. (2008) Recombinant antibodies for cancer therapy. Expert Opin. Biol. Ther. 8, 1123-41.
3. Wu, A. M., and Senter, P. D. (2005) Arming antibodies: prospects and challenges for immunoconjugates. Nat. Biotechnol. 23, 1137-46.
4. Schrama, D., Reisfeld, R. A., and Becker, J. C. (2006) Antibody targeted drugs as cancer therapeutics. Nat. Rev. Drug Discovery 5, 147-59.
5. Lambert, J. M. (2005) Drug-conjugated monoclonal antibodies for the treatment of cancer. Curr. Opin. Pharmacol. 5, 543-9.
6. Stimmel, J. B., Merrill, B. M., Kuyper, L. F., Moxham, C. P., and Hutchins, J. T. (2000) Site-specific conjugation of serine f cysteine variant monoclonal antibodies. J. Biol. Chem. 275, 30445-50.
7. Albrecht, H., Burke, P. A., Natarajan, A., Xiong, C. Y., and Kalicinsky, M. (2004) Production of soluble ScFvs with C-terminal-free thiol for site-specific conjugation or stable dimeric ScFvs on demand. Bioconjugate Chem. 15, 16-26.
8. Carrico, I. S., Carlson, B. L., and Bertozzi, C. R. (2007) Introducing genetically encoded aldehydes into proteins. Nat. Chem. Biol. 3, 321-2.
9. Kiick, K. L., Saxon, E., Tirrell, D. A., and Bertozzi, C. R. (2002) Incorporation of azides into recombinant proteins for chemo-selective modification by the Staudinger ligation. Proc. Natl. Acad. Sci. U.S.A. 99, 19-24.
10. Davis, B. G., Lloyd, R. C., and Bryan Jones, J. (1998) Controlled site-selective glycosylation of proteins by a combined site-directed mutagenesis and chemical modification approach. J. Org. Chem. 63, 9614-5.
11. Ramakrishnan, B., and Qasba, P. K. (2002) Structure-based design of beta 1,4-galactosyltransferase I (beta 4Gal-T1) with equally efficient N-acetylgalactosaminyltransferase activity: point mutation broadens beta 4Gal-T1 donor specificity. J. Biol. Chem. 277, 20833-9.
12. Boeggeman, E., Ramakrishnan, B., Kilgore, C., Khidekel, N., Hsieh-Wilson, L. C., Simpson, J. T., and Qasba, P. K. (2007) Direct identification of nonreducing GlcNAc residues on N-glycans of glycoproteins using a novel chemoenzymatic method. Bioconjugate Chem. 18, 806-14.
13. Pasek, M., Ramakrishnan, B., Boeggeman, E., Manzoni, M., Waybright, T. J., and Qasba, P. K. (2009) Bioconjugation and detection of lactosamine moiety using alpha1,3-Galactosyltransferase mutants that transfer C2-modified galactose with a chemical handle. Bioconjugate Chem. 20, 609-18.
14. Qasba, P. K., Boeggeman, E., and Ramakrishnan, B. (2008) Site-specific linking of biomolecules via glycan residues using glycosyltransferases. Biotechnol. Prog. 24, 520-6.
15. Ramakrishnan, B., Boeggeman, E., and Qasba, P. K. (2007) Novel method for in vitro O-glycosylation of proteins: application for bioconjugation. Bioconjugate Chem. 18, 1912-8.
16. Gerken, T. A., Raman, J., Fritz, T. A., and Jamison, O. (2006) Identification of common and unique peptide substrate preferences for the UDP-GalNAc:polypeptide alpha-N-acetylgalactosaminyltransferases T1 and T2 derived from oriented random peptide substrates. J. Biol. Chem. 281, 32403-32416.
17. Hubé, F., Mutawe, M., Leygue, E., and Myal, Y. (2004) Human small breast epithelial mucin: the promise of a new breast tumor biomarker. DNA Cell Biol. 23, 842-9.
18. Boeggeman, E. E., Ramakrishnan, B., and Qasba, P. K. (2003) The N-terminal stem region of bovine and human beta1,4-galactosyltransferase I increases the in vitro folding efficiency of their catalytic domain from inclusion bodies. Protein Expr. Purif. 30, 219-29.
19. Ten Hagen, K. G., Fritz, T. A., and Tabak, L. A. (2003) All in the family: the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases. Glycobiology 13, 1R-16R.
20. Kubota, T., Shiba, T., Sugioka, S., Furukawa, S., Sawaki, H., Kato, R., Wakatsuki, S., and Narimatsu, H. (2006) Structural basis of carbohydrate transfer activity by human UDP-GalNAc: polypeptide alpha-N- acetylgalactosaminyltransferase (pp-Gal-NAc-T10). J. Mol. Biol. 359, 708-27.
21. Peipp, M., Saul, D., Barbin, K., Bruenke, J., Zunino, S. J., Niederweis, M., and Fey, G. H. (2004) Efficient eukaryotic expression of fluorescent scFv fusion proteins directed against CD antigens for FACS applications. J. Immunol. Methods 285, 265-80.
22. Freire, T., Lo-Man, R., Piller, F., Piller, V., Leclerc, C., and Bay, S. (2006) Enzymatic large-scale synthesis of MUC6-Tn glycoconjugates for antitumor vaccination. Glycobiology 16, 390-401.